Bromantane - DrugsPRO substance guide

Bromantane: Marketed in Russia as Ladasten for neurasthenia; banned by WADA since 1996. Enhances physical endurance through upregulation of dopamine synthesis enzymes rather than direct reuptake inhibition. Shows immunomodulatory and anti-inflammatory effects. Synergizes strongly with stimulants—pot

Related pages